THE ANTITUMOR EFFICACY OF HUMAN RECOMBINANT INTERLEUKIN-2 - CORRELATION BETWEEN SENSITIVITY OF TUMORS TO THE CYTOLYTIC EFFECT OF LAK CELLS-INVITRO AND THEIR SUSCEPTIBILITY TO INTERLEUKIN-2 IMMUNOTHERAPY INVIVO

被引：0
|
作者：
BUBENIK, J
INDROVA, M
机构：
来源：
CANCER IMMUNOLOGY IMMUNOTHERAPY | 1987年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：269 / 271
页数：3
相关论文
共 50 条
  • [1] ANTITUMOR EFFICACY OF HUMAN RECOMBINANT INTERLEUKIN-2
    BUBENIK, J
    KIELER, J
    INDROVA, M
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (11): : 1738 - 1738
  • [2] ADOPTIVE IMMUNOTHERAPY OF HUMAN MENINGEAL GLIOMATOSIS AND CARCINOMATOSIS WITH LAK CELLS AND RECOMBINANT INTERLEUKIN-2
    SHIMIZU, K
    OKAMOTO, Y
    MIYAO, Y
    YAMADA, M
    USHIO, Y
    HAYAKAWA, T
    IKEDA, H
    MOGAMI, H
    [J]. JOURNAL OF NEUROSURGERY, 1987, 66 (04) : 519 - 521
  • [3] INDUCTION OF CYTOLYTIC CELLS BY PURE RECOMBINANT HUMAN INTERLEUKIN-2
    DEVOS, R
    PLAETINCK, G
    FIERS, W
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1984, 14 (11) : 1057 - 1060
  • [4] ADOPTIVE IMMUNOTHERAPY OF ESTABLISHED PULMONARY METASTASES WITH LAK CELLS AND RECOMBINANT INTERLEUKIN-2
    MULE, JJ
    SHU, SY
    SCHWARZ, SL
    ROSENBERG, SA
    [J]. SCIENCE, 1984, 225 (4669) : 1487 - 1489
  • [5] LOCAL ADOPTIVE IMMUNOTHERAPY OF ADVANCED HEAD AND NECK TUMORS WITH LAK CELLS AND INTERLEUKIN-2
    SQUADRELLISARACENO, M
    RIVOLTINI, L
    CANTU, G
    RAVAGNANI, F
    PARMIANI, G
    MOLINARI, R
    [J]. TUMORI, 1990, 76 (06) : 566 - 571
  • [6] INVITRO AND INVIVO EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-2 IN NAIVE MINIATURE SWINE
    NAKAJIMA, K
    SMITH, CV
    MIXON, A
    SYKES, M
    GUZZETTA, PC
    SPITZER, TR
    ECKHAUS, MA
    SACHS, DH
    [J]. JOURNAL OF IMMUNOTHERAPY, 1992, 11 (03): : 169 - 175
  • [7] THE IMMUNOPHARMACOLOGY, TOXICITY, AND ANTITUMOR EFFICACY OF A NOVEL RECOMBINANT INTERLEUKIN-2
    BRADLEY, EC
    KONRAD, MW
    ISSELL, BF
    [J]. CANCER INVESTIGATION, 1986, 4 (05) : 490 - 490
  • [8] LOCAL CONDITIONS IN THE HOST INFLUENCE IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LAK CELLS
    STELLER, EP
    OTTOW, RT
    EGGERMONT, AMM
    MARQUET, RL
    SUGARBAKER, PH
    [J]. CANCER DETECTION AND PREVENTION, 1988, 12 (1-6): : 81 - 90
  • [9] INTERLEUKIN-2 (IL2) SYNERGIZES WITH GAMMA-INTERFERON (GAMMA-IFN) TO GENERATE LAK CELLS-INVITRO AND INVIVO
    MAZUMDER, A
    AGAH, R
    MALLOY, B
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 365 - 365
  • [10] INVIVO ADMINISTRATION OF PURIFIED HUMAN INTERLEUKIN-2 TO PATIENTS WITH CANCER - DEVELOPMENT OF INTERLEUKIN-2 RECEPTOR POSITIVE CELLS AND CIRCULATING SOLUBLE INTERLEUKIN-2 RECEPTORS FOLLOWING INTERLEUKIN-2 ADMINISTRATION
    LOTZE, MT
    CUSTER, MC
    SHARROW, SO
    RUBIN, LA
    NELSON, DL
    ROSENBERG, SA
    [J]. CANCER RESEARCH, 1987, 47 (08) : 2188 - 2195
12345